資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/34884
|
| 標題: | Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway-A translational study |
| 作者: | Chang, Wei-Ting
Wu, Chia-Chun
Liao, I-Chuang
Lin, Yu-Wen
Chen, Yi-Chen
Ho, Chung-Han
Lee, Wei-Chieh
Lin, You-Cheng
Chen, Zhih-Cherng
Shih, Jhih-Yuan
Wu, Nan-Chun
Kan, Wei-Chih |
| 貢獻者: | Natl Sun Yat sen Univ, Sch Med
Natl Sun Yat sen Univ, Coll Med, Doctoral Program Clin & Expt Med
Natl Sun Yat sen Univ, Ctr Excellence Metab Associated Fatty Liver Dis
Chi Mei Med Ctr, Dept Internal Med, Div Cardiol
Southern Taiwan Univ Sci & Technol, Dept Biotechnol
Chi Mei Med Ctr, Dept Internal Med, Div Nephrol
Chi Mei Med Ctr, Dept Pathol
Chi Mei Med Ctr, Dept Hosp & Hlth Care Adm
Chia Nan Univ Pharm & Sci, Dept Pharm
Chi Mei Med Ctr, Dept Surg, Div Plast & Reconstruct Surg
Chi Mei Med Ctr, Dept Surg, Div Cardiovasc Surg
Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm
Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol |
| 關鍵字: | Doxorubicin-induced nephrotoxicity
Apoptosis
ROS |
| 日期: | 2023 |
| 上傳時間: | 2024-12-25 11:05:04 (UTC+8) |
| 出版者: | ELSEVIER SCIENCE INC |
| 摘要: | Doxorubicin (Dox) is a potent anticancer agent, but its associated organ toxicity, including nephrotoxicity, restricts clinical applications. Dapagliflozin (DAPA), a sodium-glucose cotransporter-2 inhibitor, has been shown to slow the progression of kidney disease in patients with and without diabetes. However, the effect of DAPA to counteract Dox-induced nephrotoxicity remains uncertain. Therefore, in this study, we aimed to elucidate the effects of DAPA in mitigating Dox-induced nephrotoxicity. We analyzed the Taiwan National Health Insurance Database to evaluate the incidence of renal failure among breast cancer patients receiving Dox treatment compared to those without. After adjusting for age and comorbidities, we found that the risk of renal failure was significantly higher in Dox-treated patients (incidence rate ratio, 2.45; confidence interval, 1.41-4.26; p = 0.0014). In a parallel study, we orally administered DAPA to Sprague-Dawley rats for 6 weeks, followed by Dox for 4 weeks. DAPA ameliorated Dox-induced glomerular atrophy, renal fibrosis, and dysfunction. Furthermore, DAPA effectively suppressed Dox-induced apoptosis and reactive oxygen species production. On a cellular level, DAPA in HK-2 cells mitigated Dox-mediated suppression of the endothelial NOS pathway and reduced Doxinduced activities of reactive oxygen species and apoptosis-associated proteins. DAPA improved Dox-induced apoptosis and renal dysfunction, suggesting its potential utility in preventing nephrotoxicity in patients with cancer undergoing Dox treatment. |
| 關聯: | Free Radical Biology and Medicine, v.208, pp.103-111 |
| 顯示於類別: | [行政單位] 456
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 2 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
